GoodRx (GDRX) director receives 73,434 RSUs vesting by 2027 meeting

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Kennedy Kelly J. reported acquisition or exercise transactions in this Form 4 filing.

GoodRx Holdings director Kelly J. Kennedy received an equity award of 73,434 restricted stock units (RSUs) of Class A common stock. The RSUs were granted at no cash cost and each unit represents a right to one share. They vest in full on the earlier of the one-year anniversary of June 16, 2026 or the 2027 Annual Meeting of Stockholders, subject to continued service. Following this grant, Kennedy holds 207,645 Class A shares/units directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kennedy Kelly J.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	73,434	$0.00	--

Holdings After Transaction: Class A Common Stock — 207,645 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSUs granted: 73,434 RSUs Grant price: $0.00 per share Holdings after grant: 207,645 shares +2 more

5 metrics

RSUs granted 73,434 RSUs Grant of restricted stock units on June 16, 2026

Grant price $0.00 per share Stated price for RSU award

Holdings after grant 207,645 shares Total direct Class A holdings following transaction

Vesting trigger date One-year anniversary of June 16, 2026 Full vesting if earlier than 2027 annual meeting

Alternative vesting date 2027 Annual Meeting RSUs vest at this meeting if earlier than anniversary

Key Terms

restricted stock units, Class A Common Stock, Annual Meeting of Stockholders

3 terms

restricted stock units financial

"Reflects restricted stock units. Each restricted stock unit represents a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"security_title: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Annual Meeting of Stockholders financial

"the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/17/2026 - 08:35 PM Accepted by SEC EDGAR 06/17/2026 - 08:35 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kennedy Kelly J.

(Last)

(First)

(Middle)

C/O GOODRX HOLDINGS, INC.

2701 OLYMPIC BOULEVARD

(Street)

SANTA MONICA

CALIFORNIA

90404

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GoodRx Holdings, Inc. [ GDRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/16/2026		A		73,434⁽¹⁾	A	$0	207,645	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date.

Remarks:

	/s/ Gracye Cheng, Attorney-in-Fact for Kelly J. Kennedy	06/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did GoodRx (GDRX) disclose for Kelly J. Kennedy?

GoodRx reported that director Kelly J. Kennedy received 73,434 restricted stock units of Class A common stock as an equity award. The grant was recorded at a price of $0.00 per share and is compensation-based, not an open-market share purchase.

How many GoodRx (GDRX) RSUs were granted to Kelly J. Kennedy and at what price?

Kennedy was granted 73,434 restricted stock units of GoodRx Class A common stock at a stated price of $0.00 per share. These RSUs are part of director compensation and convert into shares when they vest, rather than being bought on the open market.

What is the vesting schedule for Kelly J. Kennedy’s GoodRx (GDRX) RSU grant?

The 73,434 GoodRx RSUs vest in full on the earlier of the one-year anniversary of June 16, 2026 or the date of the 2027 Annual Meeting of Stockholders. Vesting is conditioned on Kennedy’s continued service through the applicable vesting date.

How many GoodRx (GDRX) shares does Kelly J. Kennedy hold after this RSU award?

After the RSU award, Kennedy’s direct holdings total 207,645 shares or share-equivalents of GoodRx Class A common stock. This figure includes the newly granted restricted stock units reported in the filing, giving a snapshot of her overall direct equity position.

Was Kelly J. Kennedy’s GoodRx (GDRX) transaction a market purchase or sale?

The transaction was a grant of restricted stock units, not a market purchase or sale. The Form 4 classifies it under code “A” as a grant, award, or other acquisition, with a price of $0.00, reflecting stock-based compensation rather than trading activity.